InvestorsHub Logo

Omar8

08/18/20 7:42 PM

#12673 RE: medical veteran #12672

MV,




"Omar- I think if they locked up any funding they would have announced it."


And the blame is on who if they didn't get the money ? What will the excuse be ? The big powers holding this tiny company down again ?


I'm going say that marketing rollout isn't going happen in 2021. I don't even think those patient studies in Houston are happening in 2020, ANYONE hear anything on them ?




"NanoLogix is discussing with domestic and international investment groups, and is seeking additional interested parties, for an investment offer of a net-revenue interest share of the N-Assay Bacteria Diagnostic and its planned associated Pretest. In exchange for an investment of up to $3 million, NanoLogix proposes a five-year 3-5% net-revenue sharing arrangement beginning with the proposed marketing rollout of the N-Assay in 2021, following planned patient studies in Houston. The funds are to be used for company expansion, development, production and marketing for the N-Assay, Pretest, and FlatPack petri plate technologies. There is no stock issuance or dilution involved with the funding proposal.